Beginning Cash: The amount of cash reported by the company on its previous statement.
Finch Therapeutics Group, Inc. (FNCH) had Beginning Cash of $27.47M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-4.83M |
|
-- |
|
-- |
|
$6.11M |
|
$-6.11M |
|
$1.27M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-6.11M |
|
$-6.07M |
|
1.61M |
|
1.61M |
|
$-3.01 |
|
$-3.01 |
|
| Balance Sheet Financials | |
$17.28M |
|
$0.51M |
|
$28.30M |
|
$45.58M |
|
$4.46M |
|
-- |
|
$26.89M |
|
$31.36M |
|
$14.22M |
|
$14.22M |
|
$14.22M |
|
1.61M |
|
| Cash Flow Statement Financials | |
$-9.09M |
|
-- |
|
-- |
|
|
Beginning Cash |
$27.47M |
$18.38M |
|
$-9.09M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.00% |
|
-34.00% |
|
-10.61% |
|
-34.00% |
|
$8.85 |
|
$-5.66 |
|
$-5.66 |
|